Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-MANECE: Minocycline vs placebo in Angelman syndrome
2013-002154-67Phase 2Active
- Sponsor
- Dra. Cristina Avendaño Solá
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Angelman syndrome (AS) comparing Minocycline with Placebo (2 arms). Primary endpoint: Change in developmental age (Merrill-Palmer-R). Started Sep 2013; status: active.
02
Drugs
minocycline
03
Conditions
Angelman syndrome (AS)
Beyond the preview
Go deeper on 2013-002154-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002154-67.